학술논문

CLINICAL FEATURES AND TREATMENT IN PATIENTS WITH ACUTE MYELOBLASTIC LEUKEMIA WITH T (3;3) (Q21; Q26.2) / INV (3) (Q21Q26.2) EXPERIENCE OF THE CETLAM GROUP